Adalimumab for Nail Psoriasis: Efficacy and Safety From the Open-Label Extension of a Phase-3, Randomized, Placebo-Controlled Trial

SKIN The Journal of Cutaneous Medicine
doi 10.25251/skin.1.supp.96
Full Text
Abstract

Available in full text

Date
Authors
Publisher

National Society for Cutaneous Medicine


Related search